New Delhi, March 28
Aurobindo Pharma Ltd on Monday said it has acquired the domestic formulation business of Veritaz for a consideration of Rs 171 crore on debt-free cash-free basis.
This acquisition vehicle will greatly help Aurobindo as a launch pad for marketing biosimilar and other products in India, the company said in a statement. —
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now




